Skip to main content

Highlights

  1. 1
    eLife · 2020
    PMID: 32667883PMCID: PMC7363447DOIFirst author8 citations

Publications

12 publications

Funding

2 grants

Active

1 grant
  • Co-I
    First-in-Class Dual AR-V7/AR-fl Molecular Glue Degrader for Prostate Cancer Treatment
    Daedalus Fund for Innovation (Weill Cornell) · 2024–2027BioPharma Alliance
    BP 242175-01
Completed grants (1)
  • KP
    Development of Selective Small Molecule AR-V7 Inhibitors for Prostate Cancer Treatment
    Daedalus Fund for Innovation (Weill Cornell) · 2021–2023BioPharma Alliance
    BP 214751-01

News mentions

External relationships

Ownership

Arma Bio, Inc.

Professional Services

Arma Bio, Inc.